Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Aug 15;202(3):386-91.
doi: 10.1086/653705.

Intracellular Casp8p41 content is inversely associated with CD4 T cell count

Nathan W Cummins  1 , Wei Jiang, John McGinty, Gary D Bren, Ronald J Bosch, Alan Landay, Steven G Deeks, Jeffrey N Martin, Daniel Douek, Michael M Lederman, Jason Brenchley, Andrew D Badley
Affiliations

Intracellular Casp8p41 content is inversely associated with CD4 T cell count

Nathan W Cummins et al. J Infect Dis. .

Abstract

Casp8p41 is a protein fragment generated by cleavage of procaspase 8 by human immunodeficiency virus (HIV) protease. We measured Casp8p41 content in memory CD4 T cells and analyzed the association of Casp8p41 content with CD4 T cell count, cross-sectionally and longitudinally. Casp8p41 content was inversely correlated with CD4 T cell count, and change in Casp8p41 content was associated with absolute CD4 T cell count with change over time. Casp8p41 change was a better predictor of CD4 T cell count change than activated CD8 T cell percentage or viral load and was comparable to bacterial 16s DNA levels. This suggests that Casp8p41 is a relevant mediator of CD4 T cell death during HIV infection.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest: A patent for Casp8p41 has been filed by Dr Andrew Badley. The remaining authors report that they do not have a commercial or other association that might pose a conflict of interest.

Figures

Figure 1
Figure 1
A, Diagram of the generation and effects of Casp8p41 in human immunodeficiency virus (HIV)–infected cells. B, Representative dot plots demonstrating the gating strategy for quantification of the percentage of memory CD4 T cells positive for Casp8p41 by flow cytometry. In total, 1.5 to 2 million events per patient were analyzed. C, Casp8p41 colocalizes with HIV p24 antigen in HIV-infected patients. D, Casp8p41 content was measured and compared in 13 HIV-uninfected and 67 HIV-infected individuals. *P < .002, Mann-Whitney test.
Figure 2
Figure 2
Cross-sectional analysis of the correlation between (A) percent memory CD4 T cells positive for Casp8p41 and absolute CD4 T cell counts (r = −0.31, P = .03) or (B) between human immunodeficiency virus level and absolute CD4 T cell counts (r = 0.006, P = .97) in 53 HIV-infected patients with active viral replication. Correlation coefficients calculated by Spearman Rank test. *P < .05 was considered statistically significant. Casp8p41 content was measured longitudinally in previously antiretroviral naive HIV-infected patients who started antiretroviral therapy and compared with the CD4 T cell count. Representative plots of the percentage memory CD4 T cells positive for Casp8p41 (circles) and CD4 T cell counts (squares) a patient with consistently decreasing Casp8p41 content (C), or a patient with increasing Casp8p41 content (D).
See this image and copyright information in PMC

References

    1. Meyaard L, Otto SA, Keet IP, Roos MT, Miedema F. Programmed death of T cells in human immunodeficiency virus infection: no correlation with progression to disease. J Clin Invest. 1994;93:982–988. - PMC - PubMed
    1. Pandolfi F, Pierdominici M, Oliva A, et al. Apoptosis-related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:450–458. - PubMed
    1. Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J Immunol. 1996;156:3509–3520. - PubMed
    1. Samuelsson A, Brostrom C, van Dijk N, Sonnerborg A, Chiodi F. Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection–correlation with clinical progression, viral load, and loss of humoral immunity. Virology. 1997;238:180–188. - PubMed
    1. Rothen M, Gratzl S, Hirsch HH, Moroni C. Apoptosis in HIV-infected individuals is an early marker occurring independently of high viremia. AIDS Res Hum Retroviruses. 1997;13:771–779. - PubMed

Publication types